Skip to content

Melanoma/Skin Cancer Health Center

Font Size

Changes to This Summary (04 / 012013)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

    General Information About Melanoma

    Recommended Related to Melanoma/Skin Cancer


    Note: Separate PDQ summaries on Skin Cancer Prevention, Skin Cancer Treatment, and Levels of Evidence for Cancer Screening and Prevention Studies are also available. Interventions The only widely proposed screening procedure for skin cancer is visual examination of the skin, including both self-examination and clinical examination. Benefits In asymptomatic populations, the effect of visual skin examination on mortality from nonmelanomatous skin cancers is unknown. Further, the evidence...

    Read the Overview article > >

    Updated statistics with estimated new cases and deaths for 2013 (cited American Cancer Society as reference 1).

    Cellular and Molecular Classification of Melanoma

    Added Carvajal et al. as reference 6.

    Stage IV and Recurrent Melanoma

    Revised text of the signal transduction inhibitors treatment option to include BRAF inhibitors.

    Added text to include a treatment option that states that clinical trials should be considered because of the advances in the development of novel agents and combinations of agents designed to reverse or interrupt aberrant molecular pathways that support tumor growth.

    Added text to state that studies to date indicate that both BRAF and MEK (mitogen-activated ERK-[extracellular signal-regulated kinase] activating kinase) inhibitors can significantly impact the natural history of melanoma, although they do not appear to provide a cure as single agents.

    Added Dabrafenib as a new subsection.

    Added MEK inhibitors as a new subsection.

    Added Combinatorial Therapy with Signal Transduction Inhibitors as a new subsection.

    Added KIT inhibitors as a new subsection.

    Added text to state that an extended schedule and escalated dose of TMZ was compared with DTIC in a multicenter trial randomly assigning 859 patients, but no improvement was seen in overall survival (OS) or progression-free survival for the TMZ group, and this dose and schedule resulted in more toxicity than the standard dose, single-agent DTIC (cited Patel et al. as reference 40 and level of evidence 1iiA).

    Added text to state that the design of two recent randomized, phase III trials in previously untreated patients with metastatic melanoma included DTIC as the standard therapy arm; vemurafenib and ipilimumab showed superior OS compared with DTIC in the two separate trials.

    Added text to include signal transduction inhibitors, including phosphoinositide-3 kinase and Akt inhibitors as a treatment option.

    Added text to the antiangiogenesis agents treatment option to state that preclinical data suggest that increased vascular endothelial growth factor production may be implicated in resistance to BRAF inhibitors (cited Martin et al. as reference 44)..

    This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

      WebMD Public Information from the National Cancer Institute

      Last Updated: February 25, 2014
      This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.

      Today on WebMD

      Malignant melanoma
      About 40-50 percent of those who live to be 65 may get it. Here’s how to spot early.
      Woman checking out tan lines
      There’s a dark side to that strive for beauty. See them here.
      sauteed cherry tomatoes
      Fight cancer one plate at a time.
      Lung cancer xray
      See it in pictures, plus read the facts.
      12 Ways to Protect Your Skin from Melanoma
      precancerous lesions slideshow
      Do You Know Your Melanoma ABCs
      15 Cancer Symptoms Men Ignore
      screening tests for men
      Vitamin D
      Is That Mole Skin Cancer
      Brilliant sun rays

      WebMD Special Sections